革命医药

关于 Revolution Medicines

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which 从事 developing novel targeted therapies. It 从事 the discovery and 开发 of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was 成立 by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is 总部位于 in Redwood City, CA.

成立时间

2004

首席执行官

Dr. Mark A. Goldsmith, M.D., PhD

员工人数

883

总部地址

Redwood City, California, United States of America

财年结束日

12-31

官方网站

revmed.com

公司概况

交易所

US

股票代码

RVMD

市值排名

#499

上市日期

2020-02-13

市值

38.14B

流通市值

32.85B

总股数

214.34M

流通股数

184.61M

行业与主题板块

浏览全部行业与主题板块